Investor Relations
Axiforge is building and deploying the Autonomous Factory — a fully proprietary autonomous production platform for small and mid-size manufacturers. The demonstrator is live and operational. Alongside this, the group designs, builds, and installs AI-driven industrial robots: cobots, multi-arm systems, and mobile platforms. Two complementary lines of activity, one proprietary AI stack. The group is raising a seed round to fund the first commercial deployments. SEIS/EIS eligible.
The Market Opportunity
Predictive maintenance and autonomous production are the fastest-growing segments in industrial technology. SME manufacturers across furniture, steel construction, food production, and medical manufacturing remain largely unserved — too fragmented for enterprise automation giants, too complex for off-the-shelf solutions.
Global SME Mfg Automation (2024)
$28B
→ $82B by 2033
SME Automation CAGR
~13%
Across all target sectors
Europe SME Manufacturing (2024)
$7.8B
→ $24B by 2033
UK SME Mfg market (2026)
$2.1B
CAGR ~14% Europe
Addressable Market — SME Manufacturing · 4 Sectors (EU + UK)
£4.2B / year
EU + UK SME manufacturing · furniture, steel, food, medical
£310M / year
UK + DE/CZ/SK · 60% reachable adoption
£190k → £4.75M ARR
20 plants Y1 · 160 Y3 · 500 Y5
Cost of the Problem — ROI Justification
£3,000–£22,000/hr
Cost of unplanned downtime across SME manufacturing sectors
79%
Of SME manufacturers experienced unplanned downtime in the last 3 years
68%
Of SME manufacturing downtime is preventable with predictive systems
£180,000+/mo
Lost by average mid-sized manufacturer from unplanned stoppages
30–50%
Reduction in unplanned downtime delivered by PdM deployment
4–8 months
Typical ROI payback period across manufacturing sectors
Fastest-growing
SME segment in manufacturing automation 2024–2030 (Grand View Research)
Only 31%
Of European SMEs currently adopting AI/digital tools — majority unserved
Up to 50%
UK Made Smarter programme covers technology adoption costs for SMEs
Within the next decade, the demand and sales model will be completely redefined.
Sources: Grand View Research, Market Data Forecast, MarketIntelo, Aberdeen Research, Deloitte Manufacturing Study, World Economic Forum SME Automation Report, ABB/Sapio Research.
Industrial Robotics Market
Axiforge builds and installs AI-driven industrial robots — cobots, multi-arm systems, and mobile platforms — as a bespoke engineering service. The market is large, underpenetrated among SMEs, and growing rapidly driven by labour costs and AI capability gains.
Global Industrial Robotics (2024)
$71B
→ $165B by 2033
Cobot Market CAGR
~19%
Fastest-growing robotics segment
SME Robotics Penetration
<12%
Globally — vast whitespace
Europe Cobot Market (2026)
$1.4B
CAGR ~21% through 2030
£50k–£300k
Typical bespoke robotic system project value per client
4–8 months
ROI payback for clients — consistent with Autonomous Factory deployments
Same AI stack
Every robot runs on Sensor SA-1 edge AI — zero incremental IP cost
Sources: IFR World Robotics 2024, MarketsandMarkets Cobot Report, Interact Analysis SME Robotics Survey, ABI Research Industrial Automation.
Who Will Buy — And Why Now
Autonomous factory and robotics demand is not speculative. It is structural — driven by labour shortages, rising wages, and a manufacturing base that is deeply underserved by existing automation suppliers. Below is the demand picture, ranked by sector.
74%
of UK manufacturing SMEs have no robot installed
MTC, 2025
104
robots per 10,000 workers in UK — only G7 below global avg of 177
IFR 2024
18→50%
of manufacturers highly automated today → by 2030
PwC, 2026
63%
of UK manufacturers plan robotics investment in the next 24 months
Make UK, 2024
Target Sectors — Ranked by Demand Signal Strength
Food & Beverage
Autonomous Factory + RoboticsUK firms
24,880 · 98.8% SMEs
EU cobot CAGR
29.1% (2025–33)
Robot installs +21%
US 2024 (IFR)
83% of F&B leaders plan AI investment in 2025. Largest UK manufacturing sector by employment (19.4%). Labour shortages and hygiene requirements are structural automation drivers.
Sources: ONS / DEFRA 2024 · IFR World Robotics 2025 · MarketDataForecast 2025 · Beverage Industry Survey 2025
Pharmaceuticals & Medical Devices
Autonomous Factory + RoboticsUK firms (medtech)
4,360 · 94% SMEs
Pharma robot CAGR
9.2% → $490M (2034)
Sector rank
#1 growth — Roland Berger
Ranked #1 fastest-growing automation sector (Roland Berger, 2025/2026). Sterility, precision, and zero-contamination requirements make autonomous production a regulatory necessity, not a cost option. 65% plan predictive maintenance AI investment.
Sources: Roland Berger Industrial Automation 2026 · DHSC/DSIT Sector Statistics 2024 · GMInsights Pharma Robots Report 2024 · Hexagon Survey 2025
Fabricated Metal Products
Autonomous Factory + RoboticsUK enterprises
~27,000 · overwhelmingly SME
Robot install CAGR
+12% since 2018 (IFR)
Employment share
13.7% of UK manufacturing
Largest UK manufacturing sector by enterprise count. MTC published a dedicated 2025 report identifying metalworking SMEs as the most underserved robotics segment. Metal & Machinery had the strongest robot growth of any sector globally in 2023.
Sources: ONS Business Counts 2024 · IFR World Robotics 2024 · MTC Robotics Report, March 2025
Electronics & Electrical Equipment
Autonomous Factory + RoboticsGlobal robot installs
129,000 units (2024)
Cobot growth
Fastest-growing vertical
UK firms
~6,000 · 95%+ SMEs
Largest sector by robot installation volume globally (IFR, 2024). Fastest-growing cobot vertical (MarketsandMarkets). Driven by data centre build-out, semiconductor reshoring, and precision assembly requirements.
Sources: IFR World Robotics 2025 · MarketsandMarkets Cobot Report 2024 · ONS Business Counts 2024
Packaging
RoboticsMarket size
$40.9B (2024)
ROI payback
18–24 months
Market CAGR
7.78% to 2035
Cross-sector application spanning food, pharma, consumer goods, and e-commerce. Packaging is typically the first production function to go lights-out. Cobot palletising and end-of-line automation growing at 10.7% CAGR through 2036.
Sources: Towards Packaging / Market Research Future 2024 · Future Market Insights 2026
Automotive Supply Chain
RoboticsUK component suppliers
2,500+
SME workforce share
40% in small firms
Retooling driver
EV transition capex
18 of the world's top 20 automotive suppliers operate in the UK. 40% of the automotive workforce is employed by small companies. EV retooling is forcing capex cycles across the entire Tier 1–3 supply chain.
Sources: SMMT Motor Industry Facts 2024 · IFR World Robotics 2025 · AMS/ABB Automotive Survey 2024
Plastics & Polymers
RoboticsUK enterprises
~5,800
Cobot usage
~10% of global demand
Key application
Injection moulding tending
~35% of polymer processors globally integrate cobots. Machine tending, quality inspection, and assembly are the primary cobot applications. High-volume, repetitive processes with strong ROI.
Sources: British Plastics Federation · ForInsights Consultancy Cobot Verticals Report 2024
Furniture & Wood Products
Autonomous FactoryUK companies
~9,000 (FIRA, 2023)
Employment
94,000
Demo 01
Active · Axiforge reference site
Axiforge's own demonstrator (Deskraft) is the active proof of concept for this sector. Robot installations in wood/furniture growing +63% YoY in Central Europe (IFR/Plastech, 2024). Highly SME-dense, low current automation — precisely the underserved profile Axiforge targets.
Sources: FIRA Statistics Digest 2023 · ONS Furniture Manufacture 2023–2025 · IFR/Plastech Europe Sectoral Data 2024
Textiles & Apparel
Autonomous FactoryUK businesses
~14,700 (ONS 2023)
Automation status
Lowest penetration
Labour intensity
Very high
One of the most labour-intensive and least-automated manufacturing sectors. High SME concentration, structural labour shortages, and rising wages are creating first-mover automation opportunity. Segment is emerging, not yet served by incumbents.
Sources: ONS Fashion & Textiles Adhoc Dataset 2023 · UKFT · IFR World Robotics 2024
$3.38B
Global cobot market by 2030
CAGR 18.9%
MarketsandMarkets 2024
>42%
of SMEs adopting automation now integrate cobots
SMEs = majority of cobot buyers
Emergen Research 2025
$119B
Dark factories (autonomous mfg) global market 2024
CAGR 8.7% through 2030
Grand View Research
Sources: IFR World Robotics 2024/2025 · MTC Global Robotics Clusters Study 2025 · Make UK Automation Report 2024 · PwC Industrial Manufacturing Outlook 2026 · Roland Berger Industrial Automation 2026 · MarketsandMarkets · Grand View Research · Interact Analysis · MarketDataForecast · ONS Business Counts 2024 · DEFRA Food Statistics Pocketbook 2025 · DHSC/DSIT Bioscience Sector Statistics 2024 · SMMT Motor Industry Facts 2024 · FIRA Statistics Digest 2023.
Three Monetisation Paths
Axiforge operates three independent but mutually reinforcing revenue models. Each generates value on its own terms — and each strengthens the others.
Technology Licensing to SME Manufacturers
Axiforge sells the Autonomous Factory system to existing manufacturers who want to reduce operating costs and modernise production. The client provides the facility and the market — Axiforge delivers the complete stack: machinery, edge AI, and monitoring OS. Revenue model: £80k–£200k deployment fee plus £15k–£40k/year software subscription per plant. At 10 clients in a single sector, ARR exceeds £1.5M with no proportional CAPEX growth. Scales like SaaS.
Deployment fee
£80k–£200k
Annual OS subscription
£15k–£40k
Client ROI payback
4–8 months
Sources: Aberdeen Research, Deloitte Manufacturing Study, ABB/Sapio Research, UK Made Smarter Programme.
Own Autonomous Factories Competing in End Markets
Axiforge builds and operates its own autonomous production facilities, competing directly in end markets on price — enabled by near-zero direct labour costs. Deskraft.pl — a fully autonomous furniture production line with AI-operated storefront, sales, logistics, and customer service — is the active proof of concept. Path 02 functions as a permanent live reference site for Path 01: every month of operational data eliminates the hardest B2B objection in industrial tech sales.
Build-Operate-Sell: High-Margin Autonomous Facilities
In high-margin, institutionally-driven sectors, Axiforge deploys the Build-Operate-Transfer (BOT) model: build a proprietary autonomous factory, operate it for 3–7 years generating EBITDA, sell to a strategic acquirer or PE — retaining the IP in HoldCo for the next deployment. First target: medical needle manufacturing in the UK.
UK Market Gap — Verified
There is no manufacturer of finished, sterile, single-use hypodermic needles in the United Kingdom. The NHS spends £70–75M per year on needles and syringes — sourced entirely from imports (BD Ireland/USA, B. Braun Germany, Asia). NHS Supply Chain Resilience Scoring introduced in 2025 gives domestic manufacturers a quantifiable procurement advantage. Neither Terumo nor Nipro operate needle injection manufacturing in the UK. Axiforge would enter as the sole domestic producer in a category with no UK peer comparison in NHS tender bids.
NHS needles & syringes/year
£70–75M
Projected EBITDA margin
28–38%
Factory exit multiple
8–14× EBITDA
Sources: NHS Supply Chain framework 2025, Coherent Market Insights, Becton Dickinson MacroTrends, Scope Research M&A Database (MMT acquisition, 13.7× EBITDA, Dec 2025).
AI Robotics — Design, Build & Install
Axiforge designs, builds, and installs AI-driven industrial robots for external clients — cobots, multi-arm systems, and mobile platforms — as a bespoke engineering service. Each deployment runs on the same proprietary edge AI stack as the Autonomous Factory. Revenue model: project fee per engagement (£50k–£300k) plus optional Sensor SA-1 monitoring subscription (£8k–£20k/year). This line generates immediate revenue without the capital requirements of full factory deployments — and every robotic client becomes a natural lead for Autonomous Factory licensing (Path 01).
Project fee per system
£50k–£300k
Monitoring subscription/year
£8k–£20k
Cross-sell to Path 01
Every client
Robot types offered
Collaborative Robots (Cobots)
Force-limited, vision-guided, ISO/TS 15066 — safe alongside human operators
Multi-Arm Systems
Welding, assembly, pick & place — custom path planning via edge AI
Mobile & Gantry Platforms
AMR, rail-mounted, overhead — autonomous navigation with machine vision
5-Year Revenue & Exit Model
Revenue trajectory and exit valuation are independent calculations. Based on SOM targets (20 → 160 → 500 plants), confirmed pricing ranges, and NHS market data. Needle factory modelled as growing to full UK market capture (£70–75M/year, sole domestic producer).
Part 1 — Annual Revenue (Y1–Y5) · All Paths Combined
| Year | Conservative | Base | Optimistic |
|---|---|---|---|
| Year 1 | £7.7M | £11.6M | £17.2M |
| Year 2 | £25.6M | £39.7M | £65.0M |
| Year 3Milestone | £37.2M | £63.4M | £103.9M |
| Year 4 | £51.7M | £85.3M | £152.5M |
| Year 5Milestone | £55.3M | £94.1M | £177.2M |
Path 03 — Needle Factory · Ramp to Full UK Market Capture
NHS spends £70–75M/year on needles and syringes — sourced entirely from imports. Axiforge enters as sole UK domestic producer with NHS Supply Chain Resilience Scoring advantage (2025).
| Year | Conservative | Base | Optimistic |
|---|---|---|---|
| Y1 — ramp | £5.8M | £5.8M | £7.2M |
| Y2 | £12.0M | £14.4M | £21.6M |
| Y3 | £18.0M | £25.2M | £39.6M |
| Y4 | £25.0M | £39.6M | £57.6M |
| Y5 — % of NHS market | £36M · 50% | £54M · 75% | £72M · 100% |
Part 2 — Exit Valuation at Year 5 · 14× EBITDA
Comparable: MMT acquisition at 13.7× EBITDA, Dec 2025 (Scope Research M&A Database). EBITDA margins by stream: deployment fees 30% · software subscriptions 75% · needle factory 28–38% · robotics monitoring 70%.
| Metric | Conservative | Base | Optimistic |
|---|---|---|---|
| Y5 Revenue | £55.3M | £94.1M | £177.2M |
| Blended EBITDA margin | 24% | 38% | 39% |
| EBITDA | £13.4M | £35.5M | £69.1M |
| Exit Value (14× EBITDA) | £187M | £497M | £967M |
Assumptions: Path 01 SOM 20 → 160 → 500 plants · deployment fee £80k–£200k (avg £140k) · subscription £15k–£40k (avg £27.5k). Path 03 NHS market £70–75M/year. Path 04 project fee £50k–£300k (avg £175k) · monitoring £8k–£20k (avg £14k). Sources: NHS Supply Chain framework 2025, Scope Research M&A Database, Grand View Research, IFR World Robotics 2024.
Frequently Asked Questions
What is Autonomous Factory and what stage is it at?
What makes Autonomous Factory different from standard industrial automation?
What is the investment instrument and what rights do investors receive?
Is Axiforge SEIS/EIS eligible?
What is the minimum investment and how does the waitlist work?
How does Axiforge generate returns for investors?
What is the proprietary IP and why does it matter?
Hardware layer (Engineering): Custom-built industrial machines with in-house mechanical design. No off-the-shelf production lines — every machine is engineered from the ground up for the specific client environment.
Intelligence layer (Systems): Sensor SA-1 edge AI nodes — proprietary sensor hardware and firmware for real-time anomaly detection, predictive maintenance, and zero-cloud operation. Designed and manufactured in-house.
Software layer (Tech): Autonomous Factory OS — monitoring dashboard, production intelligence, AI Advisor, and remote operations. Built on top of the same sensor data the hardware generates.
This vertical integration is the moat. Competitors who assemble third-party components cannot replicate it — and clients who deploy Autonomous Factory become dependent on a single accountable partner across all layers.
Does Axiforge build and install industrial robots?
How do I get more information?
One project. Four companies.
Autonomous Factory is a cross-company initiative spanning the entire Axiforge Group — each subsidiary contributes a distinct layer of the same system.
Engineering
The hardware layer of Autonomous Factory — bespoke industrial machinery, cobots, multi-arm systems, and mobile robotic platforms designed and built in-house. Proprietary mechanical IP at the core. No off-the-shelf lines. Every machine is ours.
Systems
The intelligence layer — proprietary Sensor SA-1 edge AI nodes powering both autonomous factory lines and every robotic system Axiforge deploys. Every machine sees, thinks, and responds without leaving the floor. No cloud. No latency.
Manufacturing
Our own manufacturing and production facility — giving us full control over every component we design, from prototype to finished product. No outsourcing. No dependencies.
Tech
The software layer of Autonomous Factory — AI Engine, production monitoring OS, and real-time decision intelligence. The operating system that keeps autonomous lines running without human intervention.
Investor Readiness Documentation
AxiForge is structured to meet the due diligence expectations of institutional and private investors. The following documents form the core of our investor data room.
Founder Agreement
Matthew Plodzien is the sole founder of AxiForge Holdings. Roles, equity and decision-making are formally defined.
- Matthew Plodzien — CEO & founding engineer
- Equity: 100% pre-seed, Class A shares (full voting)
- Vesting: 4-year schedule, 1-year cliff
- IP assignment clause: all inventions assigned to the company
Incorporation Documents
AxiForge Holdings Ltd is incorporated in England & Wales and registered at Companies House.
- Registered in England & Wales
- Status: Active
- SEIS/EIS eligibility: advance assurance being sought from HMRC
- Subsidiaries: Engineering, Systems, Tech, Manufacturing PL
Shareholders Agreement
Governs the relationship between the founder (Class A) and future investors (Class B) after SAFE conversion.
- Class A: Matthew Plodzien — voting rights, operational control
- Class B: investors — full economic rights, no voting
- Liquidation preference: 1× non-participating
- Drag-along / tag-along provisions included
Cap Table
Full equity register available to verified investors. Pre-seed cap table reflects 100% founder ownership.
- Pre-seed: Matthew Plodzien 100%
- SAFE conversion trigger: qualified priced round, exit, or IPO
- Valuation cap: £800,000 · Discount: 20%
- ESOP pool: planned post-seed
IP Assignment Agreement
All intellectual property developed by the founder and contractors is legally assigned to AxiForge.
- Sensor SA-1 firmware & edge AI: company-owned
- Autonomous Factory OS source code: company-owned
- Trademarks: AxiForge, Sensor, Autonomous Factory
Employee Contracts
All key collaborators and contractors operate under NDA and IP assignment agreements governed by English law.
- NDA mandatory for all contractors and advisors
- IP ownership clause in all engagement agreements
- Non-compete clause: 12 months post-engagement
- Jurisdiction: England & Wales
Terms of Service
ToS governs use of AxiForge software platforms — Autonomous Factory OS and FilterMail SaaS.
- Scope: Autonomous Factory OS, FilterMail, Sensor dashboard
- SLA: 99.5% uptime commitment (production tier)
- Limitation of liability: capped at 12 months of fees
- Governing law: England & Wales
Privacy Policy
GDPR-compliant data handling across all AxiForge platforms and customer touchpoints.
- Data collected: Sensor telemetry, production metrics, contact data
- No sale or transfer of customer data to third parties
- Retention policy: operational data 24 months, financial records 7 years
- DPA in place with Resend (email) and Stripe (payments)
Financial Model
3-year bottom-up financial model available to investors after joining the waitlist.
- Y1: £190k ARR — 20 plant deployments
- Y3: ~£1.5M ARR — 160 deployments
- Y5: £4.75M ARR — 500 plants
- Seed runway: 18 months post-close
Pitch Deck
20-slide investor deck covering the opportunity, technology, traction and the ask.
- Problem: £6k–£18k/hr unplanned downtime in SME food manufacturing
- Solution: Autonomous Factory — full-stack proprietary platform
- Traction: demonstrator live and operational
- Ask: seed round · SEIS/EIS eligible · £800k valuation cap
Business Plan
Detailed execution roadmap from first commercial deployment through to Series A and international scale.
- Phase 1: European SME market — live demonstrator → 20 pilot clients
- Phase 2: UK market entry — direct sales + Made Smarter programme
- Phase 3: DE / CZ / SK expansion via OEM licensing
- Revenue streams: deployment contracts, software licences, support retainers
Financial Statements
AxiForge is currently pre-revenue, in the R&D and demonstrator phase. Statements available on request.
- Stage: pre-revenue — demonstrator operational, first contracts pending
- Use of seed funds: 40% R&D, 30% sales & marketing, 20% manufacturing, 10% legal & admin
- P&L, balance sheet and cash flow provided in data room
- Audited accounts: available post first full trading year
Board Resolution Templates
Formal board resolutions are documented for all major company decisions, as required by investors and banks.
- Resolution: authorisation of SAFE instrument and seed fundraise
- Resolution: issuance of Class B shares upon SAFE conversion
- Resolution: opening of business banking accounts
- Resolution: appointment of advisors and key roles
Investment Memorandum
The full IM provides a comprehensive overview of the investment opportunity for serious investors.
- Executive summary: Autonomous Factory seed round
- Market: £830M TAM · SME food manufacturing EU + UK
- Financials & projections: 3-year model enclosed
- Risk factors, use of funds and exit scenarios included
Due Diligence Checklist
A structured data room is available to verified investors following NDA execution.
- Corporate: incorporation, bylaws, board resolutions, registers
- Governance & ownership: cap table, founder & shareholder agreements
- Legal & IP: patent application, IP assignments, contracts
- Financial: model, statements, use of funds, tax filings
Invest in the Future of British Engineering
Axiforge Holdings is structured for SEIS and EIS investment under HMRC guidelines, offering significant tax advantages for UK-based investors.
SEIS — Seed Enterprise
- Up to 50% income tax relief
- CGT exemption on gains
- Loss relief available
- EIS progression pathway
EIS — Enterprise Investment
- Up to 30% income tax relief
- CGT deferral relief
- IHT business relief (2yr)
- Unlimited qualifying investment
Tax treatment depends on individual circumstances and may be subject to change. This is not financial advice. Always seek independent qualified financial guidance before investing.